PMID: 6111227Apr 1, 1981Paper

Dopamine receptors, neuroleptics, and schizophrenia

The American Journal of Psychiatry
S H Snyder

Abstract

The antipsychotic effects of neuroleptic drugs are mediated by dopamine DA-2 receptors, and dopamine DA-1 receptors, linked to cyclic AMP formation, are not involved. Dopamine receptor binding is enhanced in brain specimens of deceased schizophrenic patients, an increase which may relate to chronic neuroleptic treatment. The binding of 3H-butyrophenones to dopamine receptors can be used for a radioreceptor assay that detects blood levels of all clinically used neuroleptics and their pharmacologically active metabolites and may facilitate routine monitoring of blood levels.

Citations

Sep 28, 2013·Biochemical Pharmacology·Raymond J WinquistMichael Williams
Jul 5, 2001·European Journal of Pharmacology·N KawashimaS Okuyama
Jan 1, 1988·Journal of Psychiatric Research·L HagenfeldtG Sedvall
Apr 1, 1995·Biological Psychiatry·D Denney, J R Stevens
Oct 1, 1983·Brain Research·R J Beninger
Jan 13, 1999·Pediatric Clinics of North America·R L FindlingJ L Blumer
Jan 1, 1986·General Pharmacology·A D OkonmahK F Soliman
Jan 1, 1983·General Pharmacology·M E Wolf, A D Mosnaim
Jun 15, 2006·Cellular and Molecular Neurobiology·Joseph T Coyle
Jan 1, 1984·Neuroscience and Biobehavioral Reviews·J L Haracz
Jan 1, 1984·Neuroscience and Biobehavioral Reviews·P L Carlton, P Manowitz
Jan 15, 2015·Schizophrenia Research·Samuel M CohenMichael M Halassa
Jun 17, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Roni ShilohDavid Manor
Dec 20, 2003·Annals of the New York Academy of Sciences·Joseph T CoyleDonald Goff
Jan 1, 1987·Magnetic Resonance Imaging·T FujimotoT Asakura
Feb 15, 1990·Biological Psychiatry·J S Bhopal
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·G Sedvall
Jan 1, 1984·Acta Psychiatrica Scandinavica. Supplementum·C HärnrydA Aberg-Wistedt
Apr 1, 1984·Journal of Clinical Pharmacology·A J GianniniM C Giannini
Apr 21, 1998·Obstetrics and Gynecology Clinics of North America·F S Coleman, J Kay
May 28, 1992·Biochemical Pharmacology·S Y AblordeppeyW M Davis
Jun 6, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Roni ShilohAvi Valevski
Aug 7, 1999·Journal of Clinical Pharmacy and Therapeutics·N Delassus-GuenaultH Robert
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Solomon H Snyder
Mar 1, 1992·The Australian and New Zealand Journal of Psychiatry·A M HassettD L Copolov
May 1, 1990·Biomedical & Environmental Mass Spectrometry·H K JajooR F Mayol
Jun 1, 1985·Journal of Autonomic Pharmacology·J P HiebleO S Steinsland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2021 Meta ULC. All rights reserved